Literature DB >> 19544204

Indication for elective neck dissection for N0 carcinoma of the parotid gland: a single institution's 20-year experience.

Ryo Kawata1, Lee Koutetsu, Katsuhiro Yoshimura, Shuji Nishikawa, Hiroshi Takenaka.   

Abstract

CONCLUSIONS: Elective neck dissection (END) may not be necessary in patients with low-grade malignancy. However, currently, END should be performed in all patients with parotid carcinoma because the preoperative diagnosis of lymph node metastasis is limited and the accuracy of preoperative grade diagnosis is low.
OBJECTIVE: Our aim was to examine the indication for END in N0 patients and the extent of dissection by investigating the accuracy of diagnosing the grade and lymph node metastasis of parotid carcinoma. PATIENTS AND METHODS: The subjects were 77 patients with parotid carcinoma. Among N0 patients, modified radical neck dissection (MRND) was conducted in those in whom the histological grade was evaluated as high, and selective neck dissection (SND) in other patients.
RESULTS: Lymph node metastasis was detected in 27 of 71 patients who underwent neck dissection. Node metastasis was detected in 19 (61.3%) of 31 patients in whom high-grade malignancy was suggested and in 8 (22.9%) of 35 patients in whom intermediate-grade malignancy was suggested preoperatively. There was no metastasis in any of the five patients in whom low-grade malignancy was suggested. Occult metastasis was noted in 8 of 51 patients. The rate at which the histological grade was accurately diagnosed before surgery was low, especially in patients with low-grade malignancy.

Entities:  

Mesh:

Year:  2010        PMID: 19544204     DOI: 10.3109/00016480903062160

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  11 in total

Review 1.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

2.  Primary parotid carcinoma: analysis of risk factors and validation of a prognostic index.

Authors:  Alberto Paderno; Michele Tomasoni; Davide Mattavelli; Simonetta Battocchio; Davide Lombardi; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-12       Impact factor: 2.503

Review 3.  Current Issues in Treatment of Parotid Gland Cancer and Advanced Surgical Technique of Robotic Parotidectomy.

Authors:  Young Min Park; Yoon Woo Koh
Journal:  Curr Oncol Rep       Date:  2022-01-21       Impact factor: 5.075

4.  Clinicopathologic study of 1176 salivary gland tumors in a Chinese population: experience of one cancer center 1997-2007.

Authors:  Yu-Long Wang; Yong-Xue Zhu; Tong-Zhen Chen; Yu Wang; Guo-Hua Sun; Ling Zhang; Cai-Ping Huang; Zhuo-Ying Wang; Qiang Shen; Duan-Shu Li; Yi Wu; Qing-Hai Ji
Journal:  Acta Otolaryngol       Date:  2012-04-12       Impact factor: 1.494

5.  Effect of clinical symptoms on the indication for selective neck dissection for N0 carcinomas of the parotid gland.

Authors:  Takashi Maruo; Yasushi Fujimoto; Kenji Yoshida; Mariko Hiramatsu; Atsushi Suzuki; Naoki Nishio; Mariko Shimono; Tsutomu Nakashima
Journal:  Oncol Lett       Date:  2014-05-12       Impact factor: 2.967

6.  Management of Salivary Gland Tumours: United Kingdom National Multidisciplinary Guidelines.

Authors:  S Sood; M McGurk; F Vaz
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

7.  Probability and pattern of occult cervical lymph node metastases in primary parotid carcinoma.

Authors:  Dominik Stodulski; Bogusław Mikaszewski; Hanna Majewska; Piotr Wiśniewski; Czesław Stankiewicz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-28       Impact factor: 2.503

8.  Sentinel lymph node biopsy in cN0 neck management of parotid cancer.

Authors:  Wenting Pan; Kai Ba; Xingyu Niu; Fei Liu; Qigen Fang
Journal:  Sci Rep       Date:  2019-06-06       Impact factor: 4.379

9.  Nodal Metastases in Acinic Cell Carcinoma of the Parotid Gland.

Authors:  Stefan Grasl; Stefan Janik; Matthaeus C Grasl; Johannes Pammer; Michael Formanek; Ilan Weinreb; Bayardo Perez-Ordonez; Andrew Hope; Ali Hosni; John R de Almeida; Jon Irish; Ralph Gilbert; David P Goldstein; Boban M Erovic
Journal:  J Clin Med       Date:  2019-08-27       Impact factor: 4.241

10.  Management of clinically negative neck in salivary gland cancers - elective neck dissection, irradiation, or surveillance?

Authors:  Mateusz Szewczyk; Paweł Golusiński; Jakub Pazdrowski; Piotr Pieńkowski; Wojciech J Golusiński
Journal:  Contemp Oncol (Pozn)       Date:  2019-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.